 | Cellectis SA (NASDAQ:CLLS) Short Interest Update
www.americanbankingnews.com - October 12 at 4:19 PM |
 | Genome Editing & Engineering Conference: 2-Day Event (San Diego, CA, United States - February 6-7, 2020) - Yahoo Finance
finance.yahoo.com - October 11 at 6:02 PM |
 | Genome Editing & Engineering Conference: 2-Day Event (San Diego, CA, United States - February 6-7, 2020) - GlobeNewswire
www.globenewswire.com - October 11 at 8:01 AM |
 | Cellectis: Monthly Information on Share Capital and Company Voting Rights - StreetInsider.com
www.streetinsider.com - October 7 at 6:26 PM |
| 2 Falling Knives Expected to Rebound - Yahoo Finance
finance.yahoo.com - October 4 at 9:42 PM |
| Form 6-K Cellectis SA For: Oct 01 - StreetInsider.com
www.streetinsider.com - October 3 at 9:32 PM |
| $1.40 Million in Sales Expected for Cellectis SA (NASDAQ:CLLS) This Quarter
www.americanbankingnews.com - October 3 at 10:38 AM |
| Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates - Yahoo Finance
finance.yahoo.com - October 3 at 3:22 AM |
 | BRIEF-Cellectis, Lonza Enter cGMP Manufacturing Service Agreement - Reuters
www.reuters.com - October 1 at 8:48 PM |
 | Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis' Allogeneic UCART Product Candidates - Business Wire
www.businesswire.com - October 1 at 8:48 PM |
| Analysts Expect Cellectis SA (NASDAQ:CLLS) to Post -$0.89 Earnings Per Share
www.americanbankingnews.com - October 1 at 9:32 AM |
| The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger - Yahoo Finance
finance.yahoo.com - September 24 at 3:44 PM |
| Cellectis SA (NASDAQ:CLLS) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - September 22 at 2:41 AM |
 | Does Cellectis S.A. (EPA:ALCLS) Have A Particularly Volatile Share Price? - Yahoo Finance UK
uk.finance.yahoo.com - September 15 at 1:34 PM |
| Does Cellectis S.A. (EPA:ALCLS) Have A Particularly Volatile Share Price?
finance.yahoo.com - September 15 at 1:34 PM |
 | 26 Healthcare Stocks Moving In Thursday's Pre-Market Session - Benzinga
www.benzinga.com - August 15 at 11:41 AM |
 | Xerox passes over several cities, including Phoenix, to bring hundreds of jobs to N.C. - Phoenix Business Journal
www.bizjournals.com - August 14 at 9:53 AM |
| Cellectis Reports Financial Results for Second Quarter and First Six Months 2019 - Yahoo Finance
finance.yahoo.com - August 7 at 9:59 PM |
 | Cellectis EPS misses by $0.29, misses on revenue - Seeking Alpha
seekingalpha.com - August 6 at 10:56 PM |
| Calyxt to Hold Second Quarter Investor Conference Call on Wednesday, August 7, at 8:30 a.m. EDT – 7:30 a.m. CDT - Yahoo Finance
finance.yahoo.com - July 22 at 7:07 PM |
| Imagine Owning Cellectis (EPA:ALCLS) And Wondering If The 45% Share Price Slide Is Justified - Yahoo Finance
finance.yahoo.com - July 17 at 8:55 AM |
| Cellectis Publishes New CAR Design to Control CAR T-Cells in Non-Lethal Way - Business Wire
www.businesswire.com - July 10 at 8:54 AM |
| Cellectis Publishes New CAR Design to Control CAR T-Cells in Non-Lethal Way - Yahoo Finance
finance.yahoo.com - July 8 at 6:24 PM |
| Cellectis Publishes New CAR Design to Control CAR T-Cells in Non-Lethal Way
finance.yahoo.com - July 8 at 6:24 PM |
| Is Solaris Oilfield Infrastructure, Inc. (SOI) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - June 27 at 8:59 AM |
| Cellectis S.A. Reports Results from Combined Shareholders Meeting Held on June 25, 2019 - Business Wire
www.businesswire.com - June 27 at 8:59 AM |
| Allogene Therapeutics Announces FDA Clearance of the IND for ALLO-715, a BCMA Allogeneic CAR T (AlloCAR T™) Therapy - GlobeNewswire
www.globenewswire.com - June 4 at 6:29 PM |
| Allogene Therapeutics Announces FDA Clearance of the IND for ALLO-715, a BCMA Allogeneic CAR T (AlloCAR T™) Therapy - Yahoo Finance
finance.yahoo.com - June 4 at 8:51 AM |
| Cellectis Reports Financial Results for First Quarter 2019
finance.yahoo.com - May 29 at 8:47 AM |
| Outlook On Cellectis Shows Bullish Short-Term Fading In Long Term - Seeking Alpha
seekingalpha.com - May 22 at 8:43 AM |
| Cellectis beats by $0.40, misses on revenue
seekingalpha.com - May 9 at 8:46 AM |
| Form 10-Q Allogene Therapeutics, For: Mar 31 - StreetInsider.com
www.streetinsider.com - May 8 at 8:47 AM |
| Cellectis Reports Financial Results for First Quarter 2019 - Yahoo Finance
finance.yahoo.com - May 8 at 8:47 AM |
| Is Fidelity Southern Corporation (LION) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - May 6 at 8:48 AM |
| Is Cellectis SA (CLLS) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - May 6 at 8:48 AM |
| Key events next week - healthcare (Part 1) - Seeking Alpha
seekingalpha.com - April 26 at 6:39 PM |
| Precision Biosciences, Recent IPO: Unique ARCUS Gene Editing And Allogeneic CAR-T Platform
seekingalpha.com - April 22 at 8:35 AM |
| Cellectis Announces Oral and Poster Presentations of Allogeneic CAR T-Cell Programs at the 2019 ASGCT Annual Meeting - Business Wire
www.businesswire.com - April 18 at 7:09 PM |
| Cellectis Announces Oral and Poster Presentations of Allogeneic CAR T-Cell Programs at the 2019 ASGCT Annual Meeting
finance.yahoo.com - April 17 at 7:04 PM |
| Allogene Therapeutics (ALLO) Announces Publication of Preclinical Study Results in Molecular Therapy Highlighting Potential for ALLO-715 in MM - StreetInsider.com
www.streetinsider.com - April 16 at 7:21 PM |
| Allogene Therapeutics Announces Publication of Preclinical Study Results in Molecular Therapy Highlighting Potential for ALLO-715 (an Anti-BCMA AlloCAR T™ Therapy) in Multiple Myeloma - GlobeNewswire
globenewswire.com - April 15 at 10:18 AM |
| Cellectis: Monthly Information on Share Capital and Company Voting Rights - Business Wire
www.businesswire.com - April 5 at 7:21 PM |
| Cellectis on go with early-stage study of CAR-T for multiple myeloma - Seeking Alpha
seekingalpha.com - April 2 at 8:58 PM |
| Cellectis (CLLS) Announces FDA Clears IND for UCARTCS1 - StreetInsider.com
www.streetinsider.com - April 2 at 8:58 PM |
| FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients
finance.yahoo.com - April 2 at 8:58 PM |
| Cellectis Enters Lease Agreement to Build Manufacturing Facility, Advancing Towards Commercialization of its UCART Portfolio
finance.yahoo.com - March 7 at 6:40 PM |
| Cellectis Publishes Novel Methods to Improve the Safety of CAR T-Cell Therapy and Prevent CRS in the Journal of Biological Chemistry
finance.yahoo.com - February 25 at 6:44 PM |
| Cellectis Appoints William Monteith as Senior Vice President U.S. Manufacturing
finance.yahoo.com - December 10 at 5:15 PM |
| Cellectis misses by $0.01, misses on revenue
seekingalpha.com - November 14 at 8:32 AM |
| Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2018
finance.yahoo.com - November 13 at 4:58 PM |
